Butanesultone is a cyclic sulfone compound. It is a colorless liquid with a pungent odor. It is synthesized by reacting butane-1,4-diol with sulfur trioxide. Butanesultone is known for its high reactivity and can be used as a precursor to various other compounds. For example, it can be used to synthesize polymers and other cyclic sulfones. Butanesultone is an important reagent in organic synthesis and has potential applications in the pharmaceutical industry.'
| ID Source | ID |
|---|---|
| PubMed CID | 15411 |
| SCHEMBL ID | 26967 |
| MeSH ID | M0040430 |
| Synonym |
|---|
| 4e0c1cli2c , |
| 5-19-01-00010 (beilstein handbook reference) |
| unii-4e0c1cli2c |
| einecs 216-647-9 |
| 1,4-butanesulfone |
| 1,4-butylene sulfone |
| brn 0110588 |
| butanesulfone |
| nsc 71999 |
| butanesultone |
| 1(4)-butanesultone |
| hsdb 5846 |
| delta-valerosultone |
| 1633-83-6 |
| nsc-71999 |
| wln: t6oswtj |
| nsc71999 |
| butane sultone |
| 1,4-butanesultone |
| .delta.-butane sultone |
| 1,4-butane sultone |
| .delta.-valerosultone |
| oxathiane 2,2-dioxide |
| 1,2-oxathiane, 2,2-dioxide |
| 1,2-oxathiane 2,2-dioxide |
| 1,4-butane sultone, >=99% |
| B0136 |
| AKOS000120475 |
| A810473 |
| [1,2]oxathiane 2,2-dioxide |
| 4-hydroxybutane-1-sulfonic acid d-sultone |
| FT-0606816 |
| 1,2-oxathiane-2,2-dione |
| 1-4-butane sultone |
| SCHEMBL26967 |
| 1,4-butane sultone [hsdb] |
| 1-butanesulfonic acid, 4-hydroxy-, .delta.-sultone |
| sulfobutylbetadex sodium impurity b [ep impurity] |
| DTXSID4061836 |
| W-107953 |
| CS-W018691 |
| mfcd00006584 |
| SY006382 |
| 1,4-butane sulton |
| F0001-0588 |
| BCP23575 |
| n1-acetyl-2-chloro-5-nitrobenzene-1-carbohydrazide |
| AS-17326 |
| Q27259464 |
| BP-31154 |
| 1,2lambda6-oxathiane-2,2-dione |
| EN300-20486 |
| 4-hydroxybutane-1-sulfonic acid delta-sultone |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.
| This Compound (40.62) All Compounds (24.57) |
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 5 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||